Bicara Therapeutics Inc. (NASDAQ: BCAX) shares are trading lower Friday following the release of updated interim data.

According to Bain Capital, global telecom M&A took a breather in Q1 2025. Deal value dropped to $16 billion—down from $22 ...

It is hard to determine which of Trump's announcements - on EU tariffs or levies on Apple imports - carries greater ...

JP Morgan analyst cautions on hardware companies' earnings reports due to demand uncertainty and tariff risks.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Ross Stores stock tanks after Q1 earnings; analysts note strong results but weak guidance due to tariff uncertainty.

Crypto sector key players deny promoting DeFi project linked to Trump. Binance founder calls out potential VC-backed smear ...

So far, cryptocurrency is not outlined in the proposed P.E.L.O.S.I. Act, a bill that would ban members of Congress from ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Analysts have set 12-month price targets for Life Time Group Hldgs, revealing an average target of $37.57, a high estimate of ...

He highlighted a disconnect between Nvidia's stated $15 billion in lost China sales, the revised fiscal 2026 (calendar 2025) ...

Uranium stocks surge Friday morning as investors digested reports that President Donald Trump will sign a series of executive ...